ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BARBARA KUCEWICZ KOPYTA MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,872Medicare Part D Prescriptions Filled, Including Refills

Rank: 114 out of 780

$895K Total Retail Price of All Prescriptions

Rank: 88 out of 780

412 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

33% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 12,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,047 724 S3 1 1
OMEPRAZOLE 715 506 2 3
SYNTHROID 714 577 3 77
METFORMIN HCL 553 397 4 8
LISINOPRIL 498 381 5 6
LEVOTHYROXINE SODIUM 387 317 6 5
ZOLPIDEM TARTRATE 341 210 7 17
PRAVASTATIN SODIUM 332 267 8 9
GABAPENTIN 325 238 9 13
AMLODIPINE BESYLATE 290 261 10 4
SIMVASTATIN 276 227 11 2
ATENOLOL 245 188 12 21
HYDROCHLOROTHIAZIDE 229 194 13 10
ATORVASTATIN CALCIUM 214 174 14 12
MELOXICAM 209 182 15 16
LOSARTAN POTASSIUM 200 145 16 18
FUROSEMIDE 200 149 16 7
POTASSIUM CHLORIDE 199 181 18 11
NEXIUM 196 145 19 22
CITALOPRAM HBR 191 131 20 23
ROPINIROLE HCL 169 94 21 87
TRAMADOL HCL 168 132 22 15
GLIMEPIRIDE 163 124 23 30
CARVEDILOL 159 115 24 14
LOVASTATIN 149 128 25 47
METOPROLOL SUCCINATE 149 136 25 20
METOPROLOL TARTRATE 147 136 27 19
FLUOXETINE HCL 144 110 28 65
CLOPIDOGREL 125 105 29 34
FENOFIBRATE 122 93 30 63
CYMBALTA 118 45 31 51
ALENDRONATE SODIUM 115 100 32 44
PLAVIX 110 103 33 45
SERTRALINE HCL 110 72 33 27
CYCLOBENZAPRINE HCL 108 36 R 35 42
WARFARIN SODIUM 108 91 35 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 82 37 26
AMITRIPTYLINE HCL 106 93 R 38 48
PANTOPRAZOLE SODIUM 106 57 38 25
NAMENDA 104 104 40 46
AMLODIPINE BESYLATE-BENAZEPRIL 97 84 41 50
POLYETHYLENE GLYCOL 3350 97 53 41 79
RAMIPRIL 96 75 43 70
JANUVIA 94 71 44 85
FLUTICASONE PROPIONATE 90 49 45 41
CRESTOR 89 71 46 32
GLIPIZIDE XL 86 86 47 176
DIGOXIN 86 86 47 56
TRIAMTERENE-HCTZ 85 85 49 37
PREDNISONE 83 78 50 40
VENLAFAXINE HCL ER 81 58 51 117
ESCITALOPRAM OXALATE 81 78 51 61
CIPROFLOXACIN HCL 80 61 53 49
ALLOPURINOL 79 73 54 29
PREMARIN 79 58 R 54 110
ISOSORBIDE MONONITRATE ER 78 62 56 60
BUMETANIDE 77 62 57 96
DONEPEZIL HCL 76 76 58 31
LIPITOR 75 68 59 175
SPIRIVA 75 60 59 72
LOSARTAN-HYDROCHLOROTHIAZIDE 74 63 61 33
BUSPIRONE HCL 73 37 62 125
METHOCARBAMOL 70 43 R 63 84
BENAZEPRIL HCL 69 59 64 59
GLYBURIDE 68 68 R 65 101
PROAIR HFA 65 52 66 62
TERAZOSIN HCL 64 52 67 160
TIZANIDINE HCL 63 27 68 82
KLOR-CON M20 62 52 69 57
PROMETHAZINE HCL 61 36 R 70 66
CEFDINIR 61 60 70 180
BISOPROLOL-HYDROCHLOROTHIAZIDE 61 61 70 95
SPIRONOLACTONE 60 54 73 53
CELEBREX 59 57 74 89
TAMSULOSIN HCL 59 58 74 36
FENTANYL 58 58 S2 76 107
MECLIZINE HCL 57 57 77 83
GLIPIZIDE 56 36 78 74
RANITIDINE HCL 54 35 79 39
TOPIRAMATE 52 47 80 145
AZITHROMYCIN 50 29 81 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 36 81 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.